Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder - StreetInsider.com
Submitted by Anonymous (not verified) on Mon, 09/14/2020 - 10:18
